TSC2 and cancer: In addition, since apoptosis induced by shTSC2 in Rb mutant cells is affected by Bcl-Xl levels, inhibitor of Bcl-2 family of proteins, such as ABT-263 or ABT-737 [18], [19], could also increase the efficacy of TSC2 inhibitor induced killing of Rb mutant cancers.